177 related articles for article (PubMed ID: 30897704)
1. Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands.
Balaguer FA; Mühlethaler T; Estévez-Gallego J; Calvo E; Giménez-Abián JF; Risinger AL; Sorensen EJ; Vanderwal CD; Altmann KH; Mooberry SL; Steinmetz MO; Oliva MÁ; Prota AE; Díaz JF
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897704
[TBL] [Abstract][Full Text] [Related]
2. Cyclostreptin and microtubules: is a low-affinity binding site required?
Prussia AJ; Yang Y; Geballe MT; Snyder JP
Chembiochem; 2010 Jan; 11(1):101-9. PubMed ID: 19946930
[TBL] [Abstract][Full Text] [Related]
3. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
4. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
[TBL] [Abstract][Full Text] [Related]
5. Interaction of a cyclostreptin analogue with the microtubule taxoid site: the covalent reaction rapidly follows binding.
Bai R; Vanderwal CD; Díaz JF; Hamel E
J Nat Prod; 2008 Mar; 71(3):370-4. PubMed ID: 18298077
[TBL] [Abstract][Full Text] [Related]
6. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
[TBL] [Abstract][Full Text] [Related]
7. Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.
Field JJ; Pera B; Calvo E; Canales A; Zurwerra D; Trigili C; Rodríguez-Salarichs J; Matesanz R; Kanakkanthara A; Wakefield SJ; Singh AJ; Jiménez-Barbero J; Northcote P; Miller JH; López JA; Hamel E; Barasoain I; Altmann KH; Díaz JF
Chem Biol; 2012 Jun; 19(6):686-98. PubMed ID: 22726683
[TBL] [Abstract][Full Text] [Related]
8. Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.
Calvo E; Barasoain I; Matesanz R; Pera B; Camafeita E; Pineda O; Hamel E; Vanderwal CD; Andreu JM; López JA; Díaz JF
Biochemistry; 2012 Jan; 51(1):329-41. PubMed ID: 22148836
[TBL] [Abstract][Full Text] [Related]
9. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
[TBL] [Abstract][Full Text] [Related]
10. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
[TBL] [Abstract][Full Text] [Related]
11. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
12. Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions.
Tang Y; Rodríguez-Salarichs J; Zhao Y; Cai P; Estévez-Gallego J; Balaguer-Pérez F; Redondo Horcajo M; Lucena-Agell D; Barasoain I; Díaz JF; Fang WS
Eur J Med Chem; 2017 Sep; 137():488-503. PubMed ID: 28624703
[TBL] [Abstract][Full Text] [Related]
13. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.
Risinger AL; Jackson EM; Polin LA; Helms GL; LeBoeuf DA; Joe PA; Hopper-Borge E; Ludueña RF; Kruh GD; Mooberry SL
Cancer Res; 2008 Nov; 68(21):8881-8. PubMed ID: 18974132
[TBL] [Abstract][Full Text] [Related]
14. Structural insight into the stabilization of microtubules by taxanes.
Prota AE; Lucena-Agell D; Ma Y; Estevez-Gallego J; Li S; Bargsten K; Josa-Prado F; Altmann KH; Gaillard N; Kamimura S; Mühlethaler T; Gago F; Oliva MA; Steinmetz MO; Fang WS; Díaz JF
Elife; 2023 Mar; 12():. PubMed ID: 36876916
[TBL] [Abstract][Full Text] [Related]
15. Effects of eribulin on microtubule binding and dynamic instability are strengthened in the absence of the βIII tubulin isotype.
Wilson L; Lopus M; Miller HP; Azarenko O; Riffle S; Smith JA; Jordan MA
Biochemistry; 2015 Oct; 54(42):6482-9. PubMed ID: 26435331
[TBL] [Abstract][Full Text] [Related]
16. βIII-Tubulin: biomarker of taxane resistance or drug target?
Karki R; Mariani M; Andreoli M; He S; Scambia G; Shahabi S; Ferlini C
Expert Opin Ther Targets; 2013 Apr; 17(4):461-72. PubMed ID: 23379899
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of microtubules by taxane diterpenoids: insight from docking and MD simulations.
Yadava U; Gupta H; Roychoudhury M
J Biol Phys; 2015 Mar; 41(2):117-33. PubMed ID: 25542396
[TBL] [Abstract][Full Text] [Related]
18. Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site.
Lo YC; Cormier O; Liu T; Nettles KW; Katzenellenbogen JA; Stearns T; Altman RB
Nat Commun; 2019 Mar; 10(1):1033. PubMed ID: 30833575
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
[TBL] [Abstract][Full Text] [Related]
20. Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites.
Field JJ; Pera B; Gallego JE; Calvo E; Rodríguez-Salarichs J; Sáez-Calvo G; Zuwerra D; Jordi M; Andreu JM; Prota AE; Ménchon G; Miller JH; Altmann KH; Díaz JF
J Nat Prod; 2018 Mar; 81(3):494-505. PubMed ID: 29023132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]